EX-99.15 OTH FIN ST 4 exhibitninetyninefifteen.txt Exhibit 99.15 Johnson & Johnson and Subsidiaries (Dollars in Millions Except Per Share Figures) Unaudited 2001 2000 1999 1998 1997 1996 Sales to customer- Domestic 19,825 17,316 15,532 12,901 11,81410,851 Sales to customer- Int'l 12,492 11,856 11,825 10,910 10,70810,536 Total Sales 32,317 29,172 27,357 23,811 22,52221,387 Cost of products sold 9,581 8,957 8,539 7,700 7,350 7,185 Selling, marketing and administrative expenses 11,260 10,495 10,065 8,525 8,185 7,848 Research expense 3,591 3,105 2,768 2,506 2,373 2,109 Purchased in-process research and development 105 66 - 298 108 - Interest income (456) (429) (266) (302) (263) (196) Interest expense, net of portion capitalized 153 204 255 186 179 176 Other expense, net 38 (61) 100 12 (10) 122 Restructuring charge 147 (33) 19 553 258 - 24,419 22,304 21,480 19,478 18,18017,244 Earnings before provision for taxes on income 7,898 6,868 5,877 4,333 4,342 4,143 Provision for taxes on income 2,230 1,915 1,604 1,232 1,237 1,185 Earnings before cumulative effect of accounting changes 5,668 4,953 4,273 3,101 3,105 2,958 Cumulative effect of accounting changes (net of tax) - - - - - - Net earnings 5,668 4,953 4,273 3,101 3,1052,958 Exhibit 99.15 Johnson & Johnson and Subsidiaries (Dollars in Millions Except Per Share Figures) Unaudited 1995 1994 1993 1992 1991 Sales to customer- Domestic 9,065 7,731 7,121 6,899 6,160 Sales to customer- International 9,472 7,723 6,756 6,701 6,050 Total Sales 18,537 15,454 13,877 13,600 12,210 Cost of products sold 6,352 5,393 4,908 4,783 4,281 Selling, marketing and administrative expenses 6,950 5,901 5,364 5,356 4,808 Research expense 1,788 1,416 1,296 1,282 1,092 Purchased in-process research and development - 37 - - 171 Interest income (151) (85) (104) (122) (123) Interest expense, net of portion capitalized 184 182 165 162 156 Other expense, net 70 (5) (71) 20 88 Restructuring charge - - - - (64) 15,193 12,839 11,558 11,481 10,409 Earnings before provision for taxes on income 3,344 2,615 2,319 2,119 1,801 Provision for taxes on income 926 654 533 547 531 Earnings before cumulative effect of accounting changes 2,418 1,961 1,786 1,572 1,270 Cumulative effect of accounting changes (net of tax) - - - (595) - Net earnings 2,418 1,961 1,786 977 1,270 Exhibit 99.15 Segments of Business Johnson & Johnson and Subsidiaries Unaudited Sales to Customers (Dollars in Millions) 2001 2000 1999 Consumer - Domestic $3,449 $3,403 3,311 International 2,871 2,868 2,937 Total 6,320 6,271 6,248 Pharmaceutical - Domestic 10,240 8,441 6,955 International 4,611 4,220 4,275 Total 14,851 12,661 11,230 Medical Dev & Diag - Domestic 6,136 5,472 5,266 International 5,010 4,768 4,613 Total 11,146 10,240 9,879 Worldwide total 32,317 29,172 27,357 Geographic Areas Johnson & Johnson and Subsidiaries Sales to Customers (Dollars in Millions) 2001 2000 1999 United States $19,825 $17,316 15,532 Europe 6,687 6,210 6,564 Western Hemisphere excluding U.S. 2,070 2,020 1,964 Asia-Pacific, Africa 3,735 3,626 3,297 Worldwide total $32,317 $29,172 27,357